1 / 5

Supplementary Figure 1

Lovastatin. 0 µM. 2.5 µM. 5 µM. 10 µM. 25 µM. 50 µM. 80. % apoptosis. 70. 60. 50. 40. 30. Docetaxel. 0nM. 20. 24h. 48h. 72h. 96h. 1nM. 2.5nM. 5nM. 10. 7.5nM. 10nM. %apoptosis. 70. 0. 60. 50. 40. 30. 20. 10. 0. 24h. 48h. 72h. A. B. Supplementary Figure 1.

garren
Download Presentation

Supplementary Figure 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lovastatin 0 µM 2.5 µM 5 µM 10 µM 25 µM 50 µM 80 % apoptosis 70 60 50 40 30 Docetaxel 0nM 20 24h 48h 72h 96h 1nM 2.5nM 5nM 10 7.5nM 10nM %apoptosis 70 0 60 50 40 30 20 10 0 24h 48h 72h A B Supplementary Figure 1

  2. 14 12 10 8 Caspase 3/7 activity (arbitrary units) HeLa 6 4 2 0 control L 12.5µM D 5nM L 12.5µM + D 5nM 9 8 7 6 HepG2 5 Caspase 3/7 activity (arbitrary units) 4 3 2 1 0 control L 12.5µM D 5nM L 12.5µM + D 5nM 9 8 7 6 5 24 h Caspase 3/7 activity (arbitrary units) H322 48 h 4 3 2 1 0 control L 12.5µM D 5nM L 12.5µM + D 5nM Supplementary Figure 2

  3. 80 † † # # 70 *** † † # # # 60 *** *** 50 *** 40 % apoptosis 30 20 *** 10 0 L 12.5µM + V 0.5nM L 12.5µM + V 1nM control L 12.5µM V 0.5nM V 1nM Supplementary Figure 3

  4. # # # *** 45 HGT-1 *** 40 HGT-1-D5 *** 35 30 % apoptosis 25 20 15 10 5 0 vinblastine +verapamil control verapamil vinblastine Supplementary Figure 4

  5. HGT-1 HGT-1-D5 Supplementary Figure 5

More Related